Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,470
Closed -$18K 8253
2018
Q3
$18K Buy
+15,470
New +$18.9K ﹤0.01% 6869
2018
Q2
Sell
-36,096
Closed -$74K 8208
2018
Q1
$74K Buy
+36,096
New +$77.6K ﹤0.01% 5435
2017
Q3
Sell
-7,735
Closed -$14K 7952
2017
Q2
$14K Buy
+7,735
New +$14.3K ﹤0.01% 6553
2017
Q1
Sell
-22,689
Closed -$38K 7920
2016
Q4
$38K Buy
+22,689
New +$39.9K ﹤0.01% 6039
2016
Q2
Sell
-3,094
Closed -$4K 7938
2016
Q1
$4K Sell
3,094
-263,498
-99% -$279K ﹤0.01% 7105
2015
Q4
$238K Buy
+266,592
New +$240K ﹤0.01% 4536
2015
Q3
Sell
-232,044
Closed -$233K 8598
2015
Q2
$233K Buy
232,044
+100,037
+76% +$113K ﹤0.01% 4736
2015
Q1
$139K Sell
132,007
-15,985
-11% -$17.1K ﹤0.01% 5168
2014
Q4
$181K Buy
+147,992
New +$211K ﹤0.01% 5147

Other funds holding SBS

UBS Group's SBS Position: Q1 2026 in Review

UBS Group increased its Sabesp (SBS) stake by 48% in Q1 2026, buying an estimated $12.8M and bringing the position to 7,170,245 shares worth $43.8M. The position accounts for 0.01% of the portfolio, ranked #1784.

UBS Group first reported a position in SBS in Q4 2014 and has held it in 46 quarters since. 245 funds tracked by Wall St. Rank hold SBS as of Q1 2026.

  • UBS Group held 7,170,245 shares of Sabesp worth $43.8M as of Q1 2026.
  • UBS Group bought 2,321,973 Sabesp shares in Q1 2026, an estimated $12.8M.
  • Sabesp made up 0.01% of UBS Group's portfolio in Q1 2026, its #1784 holding.
  • UBS Group first reported a position in Sabesp in Q4 2014 and has held it in 46 quarters since.
  • 245 funds tracked by Wall St. Rank held Sabesp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.